Endoscopy
DOI: 10.1055/a-2652-8596
Original article

Added value of a balloon-based mucosal exposure device in computer-aided detection-assisted colonoscopy: a randomized controlled trial (COMBAT study)

1   Gastroenterology Unit, Valduce Hospital, Como, Italy (Ringgold ID: RIN9349)
2   Department of Gastroenterology and Hepatology, IRCCS Foundation Ca’ Granda Ospedale Maggiore Policlinico, University of Milan, Milan, Italy (Ringgold ID: RIN9304)
,
1   Gastroenterology Unit, Valduce Hospital, Como, Italy (Ringgold ID: RIN9349)
,
Saverio Alicante
3   Gastroenterology and Digestive Endoscopy Unit, Maggiore Hospital Crema, Crema, Italy (Ringgold ID: RIN18550)
,
Andrea Buda
4   Department of Gastrointestinal Oncological Surgery, Gastroenterology Unit, Presidio Ospedale Santa Maria del Prato, Feltre, Italy (Ringgold ID: RIN18557)
,
Francesco Segatta
1   Gastroenterology Unit, Valduce Hospital, Como, Italy (Ringgold ID: RIN9349)
2   Department of Gastroenterology and Hepatology, IRCCS Foundation Ca’ Granda Ospedale Maggiore Policlinico, University of Milan, Milan, Italy (Ringgold ID: RIN9304)
,
Silvia Paggi
1   Gastroenterology Unit, Valduce Hospital, Como, Italy (Ringgold ID: RIN9349)
,
Nicolò Bina
1   Gastroenterology Unit, Valduce Hospital, Como, Italy (Ringgold ID: RIN9349)
,
Dhanai Di Paolo
1   Gastroenterology Unit, Valduce Hospital, Como, Italy (Ringgold ID: RIN9349)
,
Giulia Scardino
1   Gastroenterology Unit, Valduce Hospital, Como, Italy (Ringgold ID: RIN9349)
,
Natalia Terreni
1   Gastroenterology Unit, Valduce Hospital, Como, Italy (Ringgold ID: RIN9349)
,
Giovanna Mandelli
1   Gastroenterology Unit, Valduce Hospital, Como, Italy (Ringgold ID: RIN9349)
,
Alida Andrealli
1   Gastroenterology Unit, Valduce Hospital, Como, Italy (Ringgold ID: RIN9349)
,
Alberto Savino
1   Gastroenterology Unit, Valduce Hospital, Como, Italy (Ringgold ID: RIN9349)
5   Gastroenterology Unit, Department of Medicine, University of Milan-Bicocca, Milan, Italy (Ringgold ID: RIN9305)
,
Alessandra Piagnani
1   Gastroenterology Unit, Valduce Hospital, Como, Italy (Ringgold ID: RIN9349)
2   Department of Gastroenterology and Hepatology, IRCCS Foundation Ca’ Granda Ospedale Maggiore Policlinico, University of Milan, Milan, Italy (Ringgold ID: RIN9304)
,
Samanta Romeo
3   Gastroenterology and Digestive Endoscopy Unit, Maggiore Hospital Crema, Crema, Italy (Ringgold ID: RIN18550)
,
Elisabetta Buscarini
3   Gastroenterology and Digestive Endoscopy Unit, Maggiore Hospital Crema, Crema, Italy (Ringgold ID: RIN18550)
,
6   Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy (Ringgold ID: RIN437807)
7   Endoscopy Unit, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy (Ringgold ID: RIN9268)
,
Alessandro Repici
6   Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy (Ringgold ID: RIN437807)
7   Endoscopy Unit, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy (Ringgold ID: RIN9268)
,
1   Gastroenterology Unit, Valduce Hospital, Como, Italy (Ringgold ID: RIN9349)
› Institutsangaben
Clinical Trial: Registration number (trial ID): NCT05829447, Trial registry: ClinicalTrials.gov (http://www.clinicaltrials.gov/), Type of Study: Multicenter Randomized Controlled Trial


Preview

Abstract

Background

Both computer-aided detection (CADe) systems and mucosal exposure devices can enhance adenoma detection during colonoscopy. This research investigates whether combining a CADe system with a balloon-based mucosal exposure device increases the identification of individuals with high risk colonoscopy findings within a fecal immunochemical test (FIT)-based organized screening program.

Methods

We conducted a multicenter, open-label, parallel-arm randomized controlled trial. FIT-positive subjects were randomized 1:1 to either CADe-assisted colonoscopy with a balloon-based mucosal exposure device (CADe+balloon arm) or CADe-assisted colonoscopy alone (CADe arm). Randomization was performed using a computer-generated block sequence, with age and sex stratified. Participants, but not endoscopists, were masked to the random assignment. The primary end point was the rate of individuals with high risk colonoscopy findings according to ESGE criteria (≥5 low risk adenomas or ≥1 advanced adenoma or ≥1 advanced serrated lesion). The key secondary end point was the adenoma detection rate (ADR).

Results

644 subjects (51.5% women) were randomized in three centers. High risk findings were observed in 19.3% (95%CI 15.0% to 23.5%) of the CADe+balloon arm and 23.1% (95%CI 18.4% to 27.8%) of the CADe arm (P = 0.24). The ADR was 55.4% (95%CI 50.1% to 60.8%) versus 59.1% (95%CI 53.8% to 64.8%) in the CADe+balloon and CADe arms, respectively (P = 0.32). No adverse events were reported.

Conclusions

In a FIT-based screening program, adding a balloon-based mucosal exposure device to CADe-assisted colonoscopy did not enhance the detection of subjects with high risk features or of neoplastic lesions. A CADe-related ceiling effect may have limited the benefit of the additional device.

Supplementary Material



Publikationsverlauf

Eingereicht: 02. Februar 2025

Angenommen nach Revision: 02. Juni 2025

Artikel online veröffentlicht:
01. August 2025

© 2025. Thieme. All rights reserved.

Georg Thieme Verlag KG
Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany